Use of a retroviral vector to study the trafficking patterns of purified ovarian tumor infiltrating lymphocytes (TIL) used in intraperitoneal adoptive immunotherapy of ovarian cancer patients. A pilot study.
Freedman
R S
RS
University of Texas M.D. Anderson Cancer Center, Department of Gynecologic Oncology, Houston, 77030, USA.
Platsoucas
C D
CD
Deisseroth
A B
AB
D017252:CD3 Complex / Q000276:immunology; D016827:CD8 Antigens / Q000276:immunology; D002478:Cells, Cultured; D002985:Clinical Protocols; D005240:Feasibility Studies; D005260:Female; D005822:Genetic Vectors; D006801:Humans; D007167:Immunotherapy; D007274:Injections, Intraperitoneal; D016246:Lymphocytes, Tumor-Infiltrating / Q000166:cytology / Q000276:immunology*; D010051:Ovarian Neoplasms / Q000628:therapy*; D010865:Pilot Projects; D012190:Retroviridae / Q000235:genetics*; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology*
D017252:CD3 Complex; D016827:CD8 Antigens